Get to know Venclexta better with 8 real example sentences.
Venclexta in a sentence
Using Venclexta
- In the example corpus, venclexta often appears in combinations such as: of venclexta, venclexta and, with venclexta.
Context around Venclexta
- Average sentence length in these examples: 17.8 words
- Position in the sentence: 4 start, 4 middle, 0 end
- Sentence types: 8 statements, 0 questions, 0 exclamations
Corpus analysis for Venclexta
- In this selection, "venclexta" usually appears near the start of the sentence. The average example has 17.8 words, and this corpus slice is mostly made up of statements.
- Around the word, names, venclyxto, works and may stand out and add context to how "venclexta" is used.
- Recognizable usage signals include brand names venclexta and venclyxto and out how venclexta works over. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "venclexta" sits close to words such as aab, aamer and aave, which helps place it inside the broader word index.
Example types with venclexta
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
VENCLEXTA may cause fertility problems in males. (7 words)
Venclexta/Venclyxto is being developed by AbbVie and Roche. (9 words)
Venclexta is being developed by AbbVie and Roche Holding AG. (10 words)
AbbVie and Swiss drug giant Roche Holding are jointly developing venetoclax, which is sold under the brand names Venclexta and Venclyxto and approved for indications in chronic lymphocytic leukemia and acute myeloid leukemia. (33 words)
Continued approval for this use may depend on the results of an ongoing study to find out how Venclexta works over a longer period of time. (26 words)
Together, the companies are committed to research with Venclexta/Venclyxto, which is currently being studied in clinical trials across several types of blood and other cancers. (26 words)
Example sentences (8)
AbbVie and Swiss drug giant Roche Holding are jointly developing venetoclax, which is sold under the brand names Venclexta and Venclyxto and approved for indications in chronic lymphocytic leukemia and acute myeloid leukemia.
Continued approval for this use may depend on the results of an ongoing study to find out how Venclexta works over a longer period of time.
Together, the companies are committed to research with Venclexta/Venclyxto, which is currently being studied in clinical trials across several types of blood and other cancers.
Venclexta and other medicines may affect each other causing serious side effects.
Venclexta is being developed by AbbVie and Roche Holding AG.
VENCLEXTA may cause fertility problems in males.
Venclexta/Venclyxto is being developed by AbbVie and Roche.
You will receive other medicines before starting and during treatment with VENCLEXTA to help reduce your risk of TLS.
Common combinations with venclexta
These word pairs occur most frequently in English texts:
- of venclexta 2×
- venclexta and 2×
- with venclexta 2×
- venclexta venclyxto 2×